Mechanisms balancing skeletal matrix synthesis and degradation. - Wikidata - wikimedia - TriplyDB

Mechanisms balancing skeletal matrix synthesis and degradation.

Mechanisms balancing skeletal matrix synthesis and degradation.

http://www.wikidata.org/entity/Q34129759

about

c-Src control of chloride channel support for osteoclast HCl transport and bone resorption Cartilage-specific deletion of ephrin-B2 in mice results in early developmental defects and an osteoarthritis-like phenotype during aging in vivo.Nonproliferative and Proliferative Lesions of the Rat and Mouse Skeletal Tissues (Bones, Joints, and Teeth)Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance.Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix.MicroRNAs and micromanaging the skeleton in disease, development and evolution Macrophage-stimulating protein and calcium homeostasis in zebrafish.The synergistic regulatory effect of Runx2 and MEF transcription factors on osteoblast differentiation markers Global analysis of gene expression in mineralizing fish vertebra-derived cell lines: new insights into anti-mineralogenic effect of vanadate The atherogenic Scarb1 null mouse model shows a high bone mass phenotype Myocyte enhancer factor-2 interacting transcriptional repressor (MITR) is a switch that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating peroxisome proliferator-activated receptor gamma-2.The non-phagocytic route of collagen uptake: a distinct degradation pathway.Spatial regulation of controlled bioactive factor delivery for bone tissue engineering.Matrix remodeling during endochondral ossification.Paget disease of bone.Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.Growth factor delivery for oral and periodontal tissue engineering.Inorganic materials for bone repair or replacement applications.Calcium signalling and calcium transport in bone disease.Development of an in vitro cell system from zebrafish suitable to study bone cell differentiation and extracellular matrix mineralization.Role of MKP-1 in osteoclasts and bone homeostasis.Qualitative Aspects of Bone Marrow Adiposity in Osteoporosis.Purinergic receptors and nucleotide processing ectoenzymes: Their roles in regulating mesenchymal stem cell functions.Inhibition of metastasis-associated gene 1 expression affects proliferation and osteogenic differentiation of immortalized human mesenchymal stem cells.Vanadate proliferative and anti-mineralogenic effects are mediated by MAPK and PI-3K/Ras/Erk pathways in a fish chondrocyte cell line.Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 Cells by estrogen and phytoestrogens.Recombinant matrix metalloproteinase-14 catalytic domain induces apoptosis in human osteoblastic SaOS-2 cells.Porphyromonas gingivalis Suppresses Differentiation and Increases Apoptosis of Osteoblasts From New Zealand Obese Mice.The effects of synthetic oligopeptide derived from enamel matrix derivative on cell proliferation and osteoblastic differentiation of human mesenchymal stem cells.Disruption of PDGFRalpha-initiated PI3K activation and migration of somite derivatives leads to spina bifida.Quantification of tartrate resistant acid phosphatase distribution in mouse tibiae using image analysis.In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro.Meckel's cartilage differentiation is dependent on hedgehog signaling.Osteopenia in Siah1a mutant mice.Comparative assessment of bone among wild-type, restricted ovulator and out-of-production hens.Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.FGF23 affects the lineage fate determination of mesenchymal stem cells.Aggrecan catabolism during mesenchymal stromal cellin vitrochondrogenesis

P2860

Q24296702-364D0D0A-B6CF-4A68-95F9-C6950194F7DB Q27325791-A9B81D2F-E15F-47DD-A5CD-B0077D833F6A Q28079465-5B534888-6AD2-405D-B7BD-1286B5C9AE1A Q33577033-B14EC56A-3CAC-4617-B8A5-54D04B42475A Q33608448-F1CE39BA-B8A3-4B3A-96FD-D49F13792CA5 Q33689739-B39D9835-F59F-472D-A3A0-ADAAF01DADB9 Q33729744-231DA5C8-26BF-4150-841A-096E960A6C72 Q33861355-858327E6-829C-45AD-8326-438F424020F1 Q33931050-B6F7BED1-69C2-4676-8BF2-FAB6480B30EF Q34386283-A2B2DDE1-6F42-43EC-9101-D2A90811002A Q34695969-5C30202F-99D2-4881-85C2-C2539A873628 Q35128318-A48E4DBF-6A8B-4B5E-BF58-F7AE0E06D0DC Q35598154-B8826B94-801F-422E-8142-C022051FF00C Q35753177-2C55D964-272C-4A2E-A0CA-56FEE6716B9E Q36029217-E884727E-E055-4200-BAFC-BEF02382BE5A Q36391637-CA950B6E-EFFF-4F6C-BCA0-0B80C7D94B18 Q36421314-97B38DD8-EECE-4F0E-B9A6-16C98CAB9A1E Q36583746-93BFAC4F-5091-453B-8BDF-BD9D106EBDE3 Q37038850-E11958CC-5E83-4054-97F0-41A2309757F4 Q37056471-8E339D4B-8B7C-4639-9EBF-EE4DDF4960D6 Q37348523-06BC1567-BBF9-4912-9E2B-CDAD47A2C43B Q37362091-B99CAEE0-4A8A-40BD-807F-1C493D5AC961 Q37363301-DC65FE09-5C0E-486E-9EB5-B5F4849B5068 Q38207600-2496AA59-165E-4C64-9C42-9659BEA31B96 Q39576488-D376FC94-4F5A-4414-9BE4-C480B491E1BA Q39997766-8149AAB7-A19F-4A9E-A25D-5A1BF413D753 Q40472853-BC76451D-BB25-422A-BF0F-CE410790554A Q40580913-45975207-5FDD-4E72-B7EA-4325B68D8A75 Q40964527-EFD57B45-1537-44A3-B93E-4B3C9D04FC28 Q41809948-AC8C6B30-CB76-40D9-9C5F-DB0F94622E8D Q42477032-902A107C-6CB0-4938-B298-21007F3D428A Q44780052-21C4413E-71F5-4FD5-BB0A-D4B946C09B83 Q44961480-8D5939CF-255F-48D0-9AB9-61F71934FCEE Q45177240-8468D8EC-FA2F-4FCF-AC8F-7693249884AA Q46621117-098D6384-B44B-48F0-8054-D9639C0D89FC Q47657801-08761495-C891-4268-A75F-E847CE4793A4 Q48810133-0F687276-041A-49B1-B495-270630D83613 Q50448979-67336087-A51D-46D8-BC21-B57B27A8B441 Q53088891-01AE44D8-E9BF-4FFC-A857-EEB7BA81F4A8 Q58294936-FBA7EE58-CDA2-4335-B3F5-A565601E2C61

P2860

Mechanisms balancing skeletal matrix synthesis and degradation.

http://www.wikidata.org/entity/Q34129759

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Mechanisms balancing skeletal matrix synthesis and degradation.

@ast

Mechanisms balancing skeletal matrix synthesis and degradation.

@en

Mechanisms balancing skeletal matrix synthesis and degradation.

@nl

type

label

Mechanisms balancing skeletal matrix synthesis and degradation.

@ast

Mechanisms balancing skeletal matrix synthesis and degradation.

@en

Mechanisms balancing skeletal matrix synthesis and degradation.

@nl

prefLabel

Mechanisms balancing skeletal matrix synthesis and degradation.

@ast

Mechanisms balancing skeletal matrix synthesis and degradation.

@en

Mechanisms balancing skeletal matrix synthesis and degradation.

@nl

P1433

Q34129759-40F548BB-69B9-486C-AD08-49D95D6AB50E

P1476

Q34129759-345B8937-98BA-4F99-813B-1DEF12636F07

P2093

Q34129759-157F5E2C-D4B2-4BFC-9614-DBFD87C4D99D

Q34129759-D14D410E-5D42-4799-97D9-D3DC5515B183

Q34129759-FD01B579-9ABE-4855-BB10-2152BBF7FD25

P2860

Q34129759-01B20093-3CF6-43DC-AD77-B5928B7408D1

Q34129759-07D92815-C5B5-46B8-AC4D-60BC10494FB0

Q34129759-0C6E0816-8E38-4E07-9AF0-806B509C2E80

Q34129759-0D2BBFBC-F109-4F45-BE22-4BF20EE36EBF

Q34129759-0E357C06-7732-4260-B93A-8E4908E86EE1

Q34129759-0E97A877-94F2-4C2B-9E1A-FF03EEC96638

Q34129759-18D42432-ED44-4B49-84C8-FA71C5442AC1

Q34129759-19145E68-25E9-46D8-B4EF-EA573B565862

Q34129759-1984F0F3-AD59-464D-B67B-9DC464E3BAFD

Q34129759-1B21DF0A-8095-48E2-86E0-01FD589A18E5

P304

Q34129759-E5449337-1B3B-4047-A6E1-129DA3AF4DE7

P31

Q34129759-FC9B8A26-E844-4325-92DE-288C6943AFFD

P356

Q34129759-B2E21896-B9DD-4BC1-9E8D-CB9D54FAD7C7

P407

Q34129759-0A13B692-D6FE-492E-A122-FAD7F4F57BAD

P433

Q34129759-114EFEBD-693A-4E41-A54C-8FBDC26B27AA

P478

Q34129759-5DE25BD1-B956-4283-8ED4-6C33E7860DF2

P577

Q34129759-BC212E10-1B90-489E-903A-984F69902C74

P5875

Q34129759-A97F1574-18B5-4950-8F52-3E096BDF5183

P698

Q34129759-943763F1-34FE-4963-ABC8-F3399054AFE1

P932

Q34129759-E983825B-A41B-430D-840E-32A3E2CEC336

P356

P1433

Biochemical Journal

P1476

Mechanisms balancing skeletal matrix synthesis and degradation.

@en

P2093

Harry C Blair

http://www.w3.org/2001/XMLSchema#string

Mone Zaidi

http://www.w3.org/2001/XMLSchema#string

Paul H Schlesinger

http://www.w3.org/2001/XMLSchema#string

P2860

Parathyroid hormone-regulated production of stem cell factor in human osteoblasts and osteoblast-like cells

Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Inhibition of Bax channel-forming activity by Bcl-2

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase

Receptors for PTH and PTHrP: their biological importance and functional properties

Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor

P304

329-341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BJ20020165

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

364

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11347995

http://www.w3.org/2001/XMLSchema#string

P698

12023876

http://www.w3.org/2001/XMLSchema#string

P932

1222578

http://www.w3.org/2001/XMLSchema#string